Role of the Fibroblast Activation Protein (FAP) as Biomarker of Fibrotic Lung Diseases
Clinical trial NCT06189820 · RECRUITING
Trial details
- NCT number
- NCT06189820
- Sponsor
- Erasme University Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-09
- Primary completion
- 2027-03-09
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.